NICE has recommended natalizumab for adults with highly active RRMS, citing pregnancy suitability, biosimilar value and NHS ...

Low proteinuria does not indicate better kidney outcomes or treatment response in patients with lupus nephritis; ...

The festive period brought some unwanted post for both Sanofi and Corcept Therapeutics in the form of FDA rejections for the ...

England's NICE is recommending natalizumab, sold as Tysabri and Tyruko, as an NHS-covered treatment option for people with ...

Clinical outcomes from routine practice confirm ocrelizumab effectiveness in relapsing MS, with low rates of disability worsening over 4 years.

The neurological disease affects approximately 2.8 million people worldwide The neurological disease affects approximately 2.8 million people worldwide Sanofi has reported positive new data from a mid ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Recurring fever?

Most people with multiple sclerosis (MS) have a type called relapsing-remitting MS (RRMS). It usually starts in your 20s or 30s. If you have RRMS, you may have attacks when your symptoms flare up.

Symptoms and frequency of relapses vary widely from person to person with the most common form of multiple sclerosis — and doctors aren’t entirely sure why. But, what exactly does a relapse look like?

MS research suggests the disease may be divided into two biological subtypes that differ in how early and aggressively nerve ...

Relapsing polychondritis is a rare degenerative condition with no cure. Treatment typically focuses on addressing symptoms and slowing the progression of the condition. Relapsing polychondritis is a ...